Principal Financial Group Inc Immunity Bio, Inc. Transaction History

Principal Financial Group Inc

$184 Billion
Q3 2025

A detailed history of Principal Financial Group Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 17,410 shares of IBRX stock, worth $36,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,410

Previous 16,253 7.12%

Holding current value

$36,212

Previous $42,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$2.24 - $3.01 $2,591 - $3,482	1,157 Added 7.12%	17,410 $42,000
Q2 2025 Aug 08, 2025	BUY	$1.89 - $3.44 $9,132 - $16,622	4,832 Added 42.31%	16,253 $42,000
Q1 2025 Apr 28, 2025	SELL	$2.32 - $3.9 $399 - $670	-172 Reduced 1.48%	11,421 $34,000
Q4 2024 Jan 31, 2025	BUY	$2.56 - $6.17 $29,678 - $71,528	11,593 New	11,593 $29,000
Q3 2024 Oct 31, 2024	SELL	$3.32 - $6.7 $95,303 - $192,330	-28,706 Reduced 69.64%	12,513 $46,000

Q2 2024 Jul 29, 2024	SELL	$4.82 - $9.15 $155,430 - $295,060	-32,247 Reduced 43.89%	41,219 $260,000
Q1 2024 Apr 29, 2024	SELL	$3.23 - $6.17 $9,102 - $17,387	-2,818 Reduced 3.69%	73,466 $394,000
Q4 2023 Feb 07, 2024	BUY	$1.25 - $5.21 $80 - $333	64 Added 0.08%	76,284 $382,000
Q3 2023 Nov 02, 2023	BUY	$1.29 - $3.1 $2,794 - $6,714	2,166 Added 2.92%	76,220 $128,000
Q2 2023 Aug 07, 2023	BUY	$1.53 - $6.41 $14,146 - $59,266	9,246 Added 14.27%	74,054 $205,000
Q1 2023 May 09, 2023	SELL	$1.35 - $4.78 $5,621 - $19,903	-4,164 Reduced 6.04%	64,808 $117,000
Q4 2022 Feb 09, 2023	BUY	$4.35 - $6.77 $51,334 - $79,892	11,801 Added 20.64%	68,972 $349,000
Q3 2022 Nov 09, 2022	BUY	$3.65 - $6.43 $6,124 - $10,789	1,678 Added 3.02%	57,171 $285,000
Q2 2022 Aug 10, 2022	BUY	$2.68 - $6.14 $26,599 - $60,939	9,925 Added 21.78%	55,493 $206,000
Q1 2022 May 09, 2022	SELL	$5.05 - $7.53 $6,302 - $9,397	-1,248 Reduced 2.67%	45,568 $256,000
Q4 2021 Feb 09, 2022	BUY	$5.67 - $10.18 $142,674 - $256,159	25,163 Added 116.21%	46,816 $285,000
Q3 2021 Nov 09, 2021	SELL	$9.17 - $14.24 $32,186 - $49,982	-3,510 Reduced 13.95%	21,653 $211,000
Q2 2021 Aug 10, 2021	BUY	$13.41 - $22.4 $15,729 - $26,275	1,173 Added 4.89%	25,163 $359,000
Q1 2021 May 24, 2021	BUY	$12.83 - $42.25 $307,791 - $1.01 Million	23,990 New	23,990 $570,000

Others Institutions Holding IBRX

# of Institutions

302

Shares Held

137M

Call Options Held

2.59M

Put Options Held

3.35M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Immunity Bio, Inc. Transaction History